Nika Pharmaceuticals NIKA
OTC NIKA
$0.41 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Nika Pharmaceuticals, Inc (NIKA) Consolidated Net Income (2021 - 2023)

Updated

Nika Pharmaceuticals (NIKA) recorded Consolidated Net Income of -$10,143 in Q3 2023, compared with -$6,339 a year earlier.

Analysis

Nika Pharmaceuticals, Inc (NIKA) Consolidated Net Income (2021 - 2023) Analysis & Trends

On a TTM basis, Nika Pharmaceuticals' Consolidated Net Income came in at -$72,569 as of Sep 30, 2023; for FY2022, it came in at -$3.18 million.

  • Across earlier years, Consolidated Net Income came in at -$14,712 in FY2021.
  • Quarterly Consolidated Net Income has ranged from -$3.16 million in Q2 2022 to $6,316 in Q1 2022 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$27,806 (Q2 2023), -$19,570 (Q1 2023) and -$15,050 (Q4 2022).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -10,143.00
Jun 30, 2023 -27,806.00
Mar 31, 2023 -19,570.00
Dec 31, 2022 -15,050.00
Sep 30, 2022 -6,339.00
Jun 30, 2022 -3.16 Mn
Mar 31, 2022 6,316.00
Dec 31, 2021 -26,124.00
Sep 30, 2021 2,699.00
Jun 30, 2021 2,959.00
Mar 31, 2021 -5,754.00
API Access

Nika Pharmaceuticals, Inc Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=NIKA&period=max&api_key=YOUR_API_KEY